| View |
|
DRP-9638-07
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Avitam 2.25
|
2 g / 250 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
05 January 2024
|
23 April 2026
|
| View |
|
DRP-12693-01
|
Metformin Hydrochloride
|
None
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic (Biguanide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 February 2023
|
07 August 2025
|
| View |
|
DRP-14171-01
|
Ketoanalogues + Essential Amino Acids
|
Ketomin
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutritional Therapy
|
4Care Lifescience Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 January 2024
|
14 July 2028
|
| View |
|
DRP-14171-02
|
Ketoanalogues + Essential Amino Acids
|
Ketosan
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutritional Therapy
|
4CARE LIFESCIENCE PRIVATE LTD.
|
India
|
CLIDP Conversion
|
25 March 2024
|
14 July 2028
|
| View |
|
DRP-14171-03
|
Ketoanalogues + Essential Amino Acids
|
Ketorich
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutritional Therapy
|
4CARE LIFESCIENCE PRIVATE LTD.
|
India
|
CLIDP Conversion
|
24 March 2024
|
14 July 2028
|
| View |
|
DRP-14171-04
|
Ketoanalogues + Essential Amino Acids
|
Ketomix
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutritional Therapy
|
4Care Lifescience Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 April 2024
|
14 July 2028
|
| View |
|
DRP-12117-01
|
Trimetazidine Dihydrochloride
|
None
|
35 mg
|
Modified-Release Tablet
|
Anti-angina
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
|
07 December 2026
|
| View |
|
DRP-13049-02
|
Citicoline (as sodium)
|
Medoline
|
500 mg
|
Film-Coated Tablet
|
Psychostimulants/Nootropics
|
HIRAL LABS LIMITED
|
India
|
CLIDP Conversion
|
31 December 2023
|
22 November 2027
|
| View |
|
DRP-11541-01
|
Clotrimazole
|
Retacloz
|
10 mg/g (1% w/w)
|
Topical Cream
|
Antifungal
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
13 December 2023
|
05 August 2026
|
| View |
|
DRP-10706-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
PTZ 4.5
|
4g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Zhuhai United Laboratories (Zhongshan) Co. Ltd.
|
China
|
CLIDP Conversion
|
13 December 2023
|
15 November 2026
|
| View |
|
DRP-10706-02
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Phytazin
|
4 g / 500mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Zhuhai United Laboratories (Zhongshan) Co., Ltd.
|
China
|
CLIDP Conversion
|
26 March 2024
|
15 November 2026
|
| View |
|
DRP-11423-02
|
Linezolid
|
Linesave
|
600 mg
|
Film-Coated Tablet
|
Antibacterial (Oxazolidinone)
|
LEE PHARMA LIMITED
|
India
|
CLIDP Conversion
|
13 December 2023
|
10 March 2027
|
| View |
|
DRP-12252-01
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Retaback-750
|
500 mg / 250 mg
|
Powder for Injection (IV/IM)
|
Antibacterial (Combination of Penicillins including BetaLactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
13 September 2023
|
04 July 2027
|
| View |
|
DRP-12252-02
|
Ampicillin (as Sodium) + Sulbactam (as Sodium)
|
Sulpisave-750
|
500mg/250mg
|
Powder for injection (IV/IM)
|
Antibacterial (Combination of Penicillins including BetaLactamase Inhibitor)
|
REYOUNG PHARMACEUTICAL CO., LTD
|
China
|
CLIDP Conversion
|
12 November 2023
|
04 July 2027
|
| View |
|
DRP-12252-03
|
Ampicillin (as Sodium) + Sulbactam (as sodium)
|
None
|
500 mg/250 mg
|
Powder for Injection (IV/IM)
|
Antibacterial (Combination of Penicillins including BetaLactamase Inhibitor
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
13 December 2023
|
04 July 2027
|
| View |
|
DRP-12252-04
|
Ampicillin (As Sodium) + Sulbactam (As Sodium)
|
Bactamed
|
500mg/250mg
|
Powder For Injection (IV/IM)
|
Antibacterial (Combination of Penicillins Including BetaLactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
24 March 2024
|
04 July 2027
|
| View |
|
DRP-12252-05
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Vigosul
|
500 mg / 250 mg
|
Powder for Injection (IV/ IM)
|
Antibacterial (Combination of Penicillins including BetaLactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
30 April 2024
|
04 July 2027
|
| View |
|
BR-1481
|
Heparin Sodium
|
Hepadur
|
1000 IU/mL
|
Solution for Injection (IV)
|
Antithrombotic agents
|
Tianjin Biochemical Pharmaceutical Co., Ltd
|
China
|
Renewal
|
05 May 2024
|
19 May 2029
|
| View |
DR-XY36725_PI_01.pdf
|
DR-XY36725
|
Levofloxacin (as hemihydrate)
|
Quiflox
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolones)
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
10 May 2024
|
29 September 2029
|
| View |
|
DRHR-2019
|
Ethyl Alcohol
|
Unbranded
|
70% (v/v)
|
Solution with Moisturizer
|
Antiseptic/Disinfectant
|
Green Cross, Incorporated
|
Philippines
|
Renewal
|
10 May 2024
|
12 July 2029
|